HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A corrigendum has been published Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Rehan, V. K. Articles by Torday, J. S. Search for Related Content PubMed PubMed Citation Articles by Rehan, V. K. Articles by Torday, J. S.

In utero nicotine exposure alters fetal rat lung alveolar type II cell proliferation, differentiation, and metabolism

Departments of ¹Pediatrics and ²Obstetrics and Gynecology, Harbor-UCLA Medical Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, David Geffen School of Medicine, University of California, Los Angeles, Torrance, California

Submitted 24 February 2006 ; accepted in final form 23 September 2006

We recently suggested that alveolar interstitial fibroblast-to-myofibroblast transdifferentiation may be a key mechanism underlying in utero nicotine-induced lung injury. However, the effects of in utero nicotine exposure on fetal alveolar type II (ATII) cells have not been fully determined. Placebo, nicotine (1 mg/kg), or nicotine (1 mg/kg) + the peroxisome proliferator-activated receptor (PPAR)- agonist prostaglandin J₂ (PGJ₂, 0.3 mg/kg) was administered intraperitoneally once daily to time-mated pregnant Sprague-Dawley rats from embryonic day 6 until their death on embryonic day 20. Fetal ATII cells were isolated, and ATII cell proliferation, differentiation (surfactant synthesis), and metabolism (metabolic profiling with the stable isotope [1,2-¹³C₂]-D-glucose) were determined after nicotine exposure in utero or in vitro. In utero nicotine exposure significantly stimulated ATII cell proliferation, differentiation, and metabolism. Although the effects on ATII cell proliferation and metabolism were almost completely prevented by concomitant treatment with PGJ₂, the effects on surfactant synthesis were not. On the basis of in utero and in vitro data, we conclude that surfactant synthesis is stimulated by nicotine's direct effect on ATII cells, whereas cell proliferation and metabolism are affected via a paracrine mechanism(s) secondary to its effects on the adepithelial fibroblasts. These data provide evidence for direct and indirect effects of in utero nicotine exposure on fetal ATII cells that could permanently alter the "developmental program" of the developing lung. More importantly, concomitant administration of PPAR- agonists can effectively attenuate many of the effects of in utero exposure to nicotine on ATII cells.

chronic lung disease; smoking; surfactant; fibroblast; peroxisome proliferator-activated receptor-

This article has been cited by other articles:

				R. Sakurai, E. Shin, S. Fonseca, T. Sakurai, A. A. Litonjua, S. T. Weiss, J. S. Torday, and V. K. Rehan 1{alpha},25(OH)2D3 and its 3-epimer promote rat lung alveolar epithelial-mesenchymal interactions and inhibit lipofibroblast apoptosis Am J Physiol Lung Cell Mol Physiol, September 1, 2009; 297(3): L496 - L505. [Abstract] [Full Text] [PDF]

				G. S. Maritz Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring Therapeutic Advances in Respiratory Disease, August 1, 2009; 3(4): 193 - 210. [Abstract] [PDF]